The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, November 23, 2022
The U.S. Food and Drug Administration approved Hemgenix (etranacogene dezaparvovec), an adeno-associated virus vector-based gene therapy for the ...
read more
Monday, November 21, 2022
Jazz Pharmaceuticals plc announced the FDA approval of a supplemental Biologics License Application (sBLA) to add a Monday/Wednesday/Friday (MWF) ...
read more
Monday, November 21, 2022
Takeda Canada announced that TAKHZYRO (lanadelumab), the first approved monoclonal antibody for the treatment of Hereditary Angioedema (HAE) has been ...
read more
Monday, November 21, 2022
Teva Pharmaceutical Industries Ltd. announced that the Company’s Board of Directors has appointed Richard Francis as President and Chief Executive ...
read more
Thursday, November 17, 2022
Regeneron Pharmaceuticals, Inc. and CytomX Therapeutics, Inc. announced a collaboration and licensing agreement to create conditionally-activated ...
read more
Thursday, November 17, 2022
Takeda announced that the randomized, Phase 3 PhALLCON trial met its primary endpoint, demonstrating that adult patients with newly-diagnosed ...
read more
Tuesday, November 15, 2022
The FDA issued a Federal Register notice, Safety and Effectiveness of Certain Naloxone Hydrochloride Drug Products for Nonprescription Use, that may ...
read more
Monday, November 14, 2022
Opiant Pharmaceuticals entered a merger agreement to be acquired by Indivior, a subsidiary of Indivior. Under the terms of the agreement, Indivior ...
read more
Monday, November 14, 2022
AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the ...
read more
Lannett Company announced that it has received approval from the US Food and Drug Administration (FDA) to manufacture Numbrino®, the company's branded...
read more
Wednesday, October 12, 2022
Agilent Technologies announced the opening of the Dissolution Center of Excellence (CoE) facility in Craven Arms, United Kingdom.
read more
Merck and Orion Co. have agreed to develop and commercialize Orion’s ODM-208 and other drugs targeting cytochrome P450 11A1 (CYP11A1), an enzyme ...
read more
Novartis announced the US Food and Drug Administration (FDA) has granted accelerated approval for Kymriah® (tisagenlecleucel) for the treatment of ...
read more
Pfizer Inc. and BioNTech SE announced the U.S. Food and Drug Administration (FDA) expanded emergency use authorization (EUA) to include a booster dose...
read more
Advarra announced the launch of the Advarra Partner Network, a standardized partnership program designed to extend the research capabilities of ...
read more